Have any question? Call Us Now?
    Upload Report

    Stem Cell Therapy in India: Cell Types, Delivery Routes and What to Verify - Eye Stem Cell Center

    MD treatment
    October 05, 2026/ 0 comment

    Stem Cell Therapy in India: Cell Types, Delivery Routes and What to Verify

    Last updated: 5 October 2026 | Author: Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience

    Stem cell therapy in India is easier to judge once you understand the basics: which cells are used, where they come from, how they are delivered and which uses are approved. This guide explains the science in simple language and ends with the checks every patient should make, especially when the eye or optic nerve is involved.

    Quick Navigation

    What Are Stem Cells?

    Stem cells are the body’s raw cells. They can renew themselves and mature into specialised cells such as blood, bone or retinal cells. Medicine uses them in two main ways: replacing a diseased blood system through transplantation, and in research aimed at repairing or protecting damaged tissue.

    Types of Stem Cells Used

    • Hematopoietic stem cells from bone marrow or blood, used in transplants
    • Mesenchymal stem cells from bone marrow, fat or umbilical cord tissue, studied for support and anti-inflammatory effects
    • Embryonic and induced pluripotent stem cells, used in laboratories to grow specialised cells such as retinal pigment epithelium
    • Autologous cells come from the patient; allogeneic cells come from a donor and need careful matching and screening

    How Cells Are Collected and Delivered

    1. Collection: bone marrow aspiration, fat tissue collection, blood draw or donated tissue
    2. Processing: laboratory preparation under quality control
    3. Delivery: intravenous, local injection or other routes set by the protocol; for the eye, routes are chosen only within approved research
    4. Follow-up: monitoring and review with your own specialist

    Established Care vs Investigational Treatment

    CategoryStatusWhat it involves
    Hematopoietic stem cell transplantation (HSCT)Established for approved indicationsLeukemia, lymphoma, thalassemia, aplastic anaemia
    Corneal limbal stem cell transplantationEstablished for selected corneal surface diseaseSpecialist corneal surgery
    Other stem cell use, including retinal and optic nerve diseaseInvestigational. Permitted only within approved clinical researchStudies on retinitis pigmentosa-type and nerve conditions

    Regulation and Approvals: What the Rules Say

    In India, stem cell use outside approved indications is classified as investigational under the National Guidelines for Stem Cell Research, 2017 (ICMR and DBT). The Health Ministry’s September 2026 advisory on regulation of stem cell therapy repeats that routine use is limited to approved indications. In practice this means a patient should be offered such treatment only as part of approved clinical research, with written informed consent.

    • Ethics committee approval is required for investigational use.
    • CDSCO permission applies to clinical trials of stem cell-derived products.
    • Trials should be listed on the Clinical Trials Registry – India (CTRI).
    • The National Medical Commission expects doctors not to market unproven treatment as established care.

    Because regulations change, verify the latest position on the official websites listed below.

    Why Eye Procedures Need Extra Caution

    The retina and optic nerve are delicate and cannot be replaced. Doctors have documented severe, permanent vision loss after unregulated stem cell injections into the eye, which is why approvals matter more here than almost anywhere else in medicine. Insist on an approved clinical protocol, a qualified ophthalmologist or retina surgeon, ethics approval and informed consent, and tell your regular eye doctor about any plan before you proceed.

    What Affects the Cost?

    The total depends on pre-treatment investigations, the type of cells and how they are processed, how many sessions are planned, the length of stay, and travel. India is generally more affordable than many Western countries, but be wary of unusually low or guaranteed-result packages. Always request an itemised written estimate.

    Questions to Ask Before You Decide

    • Is this part of an approved protocol, and can you show the registration number?
    • Who will perform the procedure, and what is their eye-surgery experience?
    • What are the risks to my remaining vision?
    • How will results be measured, and by whom?
    • What exactly is included in the cost, in writing?
    • Will my own eye specialist be kept informed?

    Frequently Asked Questions

    What is the difference between stem cell treatment and stem cell therapy?

    The terms are used interchangeably. What matters is whether the use is approved, and by whom.

    Which stem cells are used for eye disease research?

    Mesenchymal cells, bone marrow-derived cells and stem cell-derived retinal cells, mainly within trials.

    Is stem cell therapy in India approved for retinal disease?

    Not as routine treatment. It is investigational and permitted only within approved clinical research.

    Are my own cells safer than donor cells?

    Using your own cells lowers rejection risk but does not remove other risks.

    How do I check a trial?

    Search it on CTRI and ask for the registration number and ethics approval.

    Final Word

    Understanding cell types and delivery routes helps you ask better questions. In India, as elsewhere, only some uses of stem cells are established; most others are research. Verify approvals and keep your own specialist involved.

    You can read about stem cell treatment in India, retinal dystrophy disease treatment in India and macular dystrophy treatment in India, or upload your reports and contact our team to talk through your reports.

    More Official Sources

    Related Readings


      Translate »